Gabelli Funds LLC Takes Position in Sharecare, Inc. (NASDAQ:SHCR)

Gabelli Funds LLC bought a new stake in Sharecare, Inc. (NASDAQ:SHCR - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 660,791 shares of the company's stock, valued at approximately $892,000. Gabelli Funds LLC owned 0.18% of Sharecare as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Sharecare during the 2nd quarter worth approximately $42,000. XTX Topco Ltd acquired a new stake in shares of Sharecare during the 2nd quarter worth approximately $42,000. Panagora Asset Management Inc. acquired a new stake in shares of Sharecare during the 2nd quarter worth approximately $56,000. Alpine Global Management LLC acquired a new stake in shares of Sharecare during the 1st quarter worth approximately $83,000. Finally, StoneX Group Inc. bought a new position in Sharecare in the 1st quarter valued at approximately $102,000. 35.08% of the stock is owned by institutional investors.

Sharecare Stock Down 0.7 %

Shares of SHCR stock traded down $0.01 during trading hours on Friday, hitting $1.41. 340,252 shares of the company's stock traded hands, compared to its average volume of 2,512,896. The stock's 50 day simple moving average is $1.39 and its 200 day simple moving average is $1.08. The stock has a market cap of $511.00 million, a PE ratio of -3.84 and a beta of 0.50. Sharecare, Inc. has a 12 month low of $0.48 and a 12 month high of $1.42.

Sharecare (NASDAQ:SHCR - Get Free Report) last posted its quarterly earnings data on Friday, August 9th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.03). Sharecare had a negative return on equity of 22.81% and a negative net margin of 33.64%. The firm had revenue of $94.27 million for the quarter, compared to analyst estimates of $90.16 million. As a group, equities research analysts expect that Sharecare, Inc. will post -0.24 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Canaccord Genuity Group reissued a "hold" rating and issued a $1.43 price objective (down previously from $2.00) on shares of Sharecare in a research note on Friday, June 21st. Canaccord Genuity Group downgraded shares of Sharecare from a "strong-buy" rating to a "hold" rating in a research note on Friday, June 21st. Finally, Morgan Stanley raised their price target on shares of Sharecare from $1.00 to $1.43 and gave the company an "equal weight" rating in a research note on Monday, June 24th.

Insiders Place Their Bets

In other Sharecare news, insider Jeffrey T. Arnold sold 177,085 shares of the firm's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $1.38, for a total value of $244,377.30. Following the completion of the sale, the insider now directly owns 4,790,406 shares in the company, valued at $6,610,760.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 29.27% of the company's stock.

Sharecare Profile

Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.